Clinical Trial Update: Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety, tolerability, and PK/PD after 4 weekly SC injections of PB1046 in subjects with stable heart failure with reduced ejecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• PB1046

Snippet

Sponsor: PhaseBio Pharmaceuticals Inc. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2022-07-14